AI-guided cardiac ultrasound image acquisition.
First FDA authorization for an AI-guided image-acquisition system.
Original FDA-clearance press release (issued under the Caption Health name, before the GE acquisition).
Not found in this research pass — verify before publishing.
Acquired by GE HealthCare in 2023, now part of GE’s portable ultrasound offering; no independent deployment figure found.
Update all material to reflect GE HealthCare ownership — do not present as an independent startup.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.
Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.